179 related articles for article (PubMed ID: 30215052)
1. Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report.
Nugroho A; Lee KW; Lee KB; Kim HS; Kim H; Yi NJ; Suh KS
Ann Hepatobiliary Pancreat Surg; 2018 Aug; 22(3):287-291. PubMed ID: 30215052
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
[TBL] [Abstract][Full Text] [Related]
4. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
5. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
Lee SD; Park SJ; Han SS; Kim SH; Kim YK; Lee SA; Ko YH; Hong EK
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):594-601. PubMed ID: 25475861
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma with shared pathologic characteristics of both hepatocellular carcinoma and cholangiocarcinoma.
Hiraoka A; Kurose K; Kumagi T; Hirooka M; Yokota T; Fujiwara T; Utsunomiya S; Hirata M; Ohtani H; Michitaka K; Horiike N; Kobayashi N; Onji M
Curr Ther Res Clin Exp; 2005 Nov; 66(6):589-97. PubMed ID: 24678077
[TBL] [Abstract][Full Text] [Related]
8. Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center.
Penzkofer L; Gröger LK; Hoppe-Lotichius M; Baumgart J; Heinrich S; Mittler J; Gerber TS; Straub BK; Weinmann A; Bartsch F; Lang H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765596
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
Huang X; Li Y; Long L
Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
[TBL] [Abstract][Full Text] [Related]
11. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
12. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
[TBL] [Abstract][Full Text] [Related]
14. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
15. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population.
Wang Y; Yang Q; Li S; Luo R; Mao S; Shen J
Clin Radiol; 2019 May; 74(5):407.e1-407.e10. PubMed ID: 30799097
[TBL] [Abstract][Full Text] [Related]
16. Breast Metastasis From a Combined Hepatocellular-Cholangiocarcinoma.
Silva M; Coelho R; Rios E; Gomes S; Carneiro F; Macedo G
ACG Case Rep J; 2019 Apr; 6(4):e00057. PubMed ID: 31616738
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study.
Kim J; Joo DJ; Hwang S; Lee JM; Ryu JH; Nah YW; Kim DS; Kim DJ; You YK; Yu HC
World J Gastrointest Surg; 2023 Jul; 15(7):1340-1353. PubMed ID: 37555110
[TBL] [Abstract][Full Text] [Related]
18. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]